Skip to main content
Signal8

Strem Brian M.

SEC insider (Form 3/4/5 filer). CIK 0001876429. President and CEO at KIORA PHARMACEUTICALS INC (KPRX). 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2026. Located in ENCINITAS, CA.

Companies Strem Brian M. has filed insider reports for

  • KIORA PHARMACEUTICALS INC (KPRX): Director, Officer, President and CEO
Strem Brian M. profile photo

Strem Brian M.

CIK: 0001876429

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (60.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

KIORA PHARMACEUTICALS INC logo
KPRX

KIORA PHARMACEUTICALS INC

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • KIORA PHARMACEUTICALS INC logo
    KPRX

    KIORA PHARMACEUTICALS INC

    Jul 1, 2026
    Tax Payment
    Direct
    1.9K shares at avg. $2.66$5K
  • KIORA PHARMACEUTICALS INC logo
    KPRX

    KIORA PHARMACEUTICALS INC

    Apr 1, 2026
    Tax Payment
    Direct
    1.9K shares at avg. $1.95$4K
  • KIORA PHARMACEUTICALS INC logo
    KPRX

    KIORA PHARMACEUTICALS INC

    Mar 6, 2026
    Award
    Direct
    16.7K shares-
  • KIORA PHARMACEUTICALS INC logo
    KPRX

    KIORA PHARMACEUTICALS INC

    Mar 3, 2026
    Tax Payment
    Direct
    238 shares at avg. $2.02$480.76
  • KIORA PHARMACEUTICALS INC logo
    KPRX

    KIORA PHARMACEUTICALS INC

    Apr 1, 2025
    Award
    Direct
    15.9K shares-

1-5 of 5